دورية أكاديمية

Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience

التفاصيل البيبلوغرافية
العنوان: Pomalidomide, Cyclophosphamide, and Dexamethasone for the Treatment of Relapsed/Refractory Multiple Myeloma: Real-World Analysis of the Pethema-GEM Experience
المؤلفون: Rodriguez-Otero, Paula, Sirvent, Maialen, González-Rodríguez, Ana Pilar, Lavilla, Esperanza, de Coca, Alfonso García, Arguiñano, José María, Martí, Josep M., Cabañas, Valentin, Motlló, Cristina, de Cabo, Erik, Encinas, Cristina, Murillo, Ilda, Hernández-Rivas, Jose Ángel, Pérez-Persona, Ernesto, Casado, Felipe, Sampol, Antonia, García, Ricarda, Blanchard, María Jesús, Anguita, Magdalena, Lafuente, Ana Paz, Iñigo, Belén, López, Aurelio, Ribas, Paz, Arnao, Mario, Maldonado, Roberto, Bladé, Joan, Mateos, María Victoria, Lahuerta, Juan José, San Miguel, Jesús F.
المصدر: Clinical Lymphoma Myeloma and Leukemia ; volume 21, issue 6, page 413-420 ; ISSN 2152-2650
بيانات النشر: Elsevier BV
سنة النشر: 2021
المجموعة: ScienceDirect (Elsevier - Open Access Articles via Crossref)
مصطلحات موضوعية: Cancer Research, Oncology, Hematology
نوع الوثيقة: article in journal/newspaper
اللغة: English
DOI: 10.1016/j.clml.2021.02.004
الإتاحة: https://doi.org/10.1016/j.clml.2021.02.004Test
https://api.elsevier.com/content/article/PII:S2152265021000653?httpAccept=text/xmlTest
https://api.elsevier.com/content/article/PII:S2152265021000653?httpAccept=text/plainTest
حقوق: https://www.elsevier.com/tdm/userlicense/1.0Test/ ; https://doi.org/10.15223/policy-017Test ; https://doi.org/10.15223/policy-037Test ; https://doi.org/10.15223/policy-012Test ; https://doi.org/10.15223/policy-029Test ; https://doi.org/10.15223/policy-004Test
رقم الانضمام: edsbas.DD131E32
قاعدة البيانات: BASE